SARS-CoV-2/COVID-19 Infection Among Health Care Workers

Summary

The present study finds opportunities and justifications, taking into consideration that the nature of professional practice in health needs scientific evidence resulting from systematic and systemic studies to strengthen the basis for the decisions made to have an impact on various levels, from the patient to health management itself. In addition, Cabo Verdean authorities may benefit from new evidence obtained by this study. It intends, in a growing number of health professionals exposed or infected with SARS-CoV-2, in the different health structures of the country, to contribute to substantiate a better perception of the problem and the required solutions. Therefore, assessing the potential risk factors for SARS-CoV-2 infection among healthcare workers will be essential to characterize virus transmission, preventing future infections in them and providing the associated healthcare. Due to the advances and important changes described, questions arise that guide this research and allow us to identify the problem.

Conditions

• SARS-CoV-2
• BCG
• Health Care Worker
• COVID-19

Interventions

OTHER

Questionaire

A questionnaire will be administered to all participants to evaluate exposures related to infection at the baseline (enrollement) - Baseline questionnaire. A Follow-up questionnaire to all participants will be done after 3 and 6 months. Capillary blood collection, for diagnosis of anti-SARS-CoV-2 Antibodies by rapid test, will be done at the first interview, for all participants (cases and controls). Collection of peripheral venous blood, for analysis of the presence and duration of anti-SARS-CoV-2 Antibodies (N and S) will be done at the first interview, and after 6 months for all participants (cases and controls).

Sponsors & Collaborators

• University of Southern Denmark

  collaborator OTHER

• Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal

  collaborator UNKNOWN

• National Institute of Public Health of Cape Verde, Praia, Cape Verde

  collaborator UNKNOWN

• Centro de Investigacao em Saude de Manhica

  collaborator OTHER

• European and Developing Countries Clinical Trials Partnership (EDCTP)

  collaborator OTHER_GOV

• Bandim Health Project, Bissau, Guinea-Bissau

  collaborator UNKNOWN

• Universidade de Cabo Verde

  lead OTHER

Principal Investigators

• Isabel I Araújo, PhD · Universidade de Cabo Verde

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-07-01

Primary Completion

2021-09-08

Completion

2023-01-31

Countries

• Cabo Verde

Study Locations